• Conference Proceeding

Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

Citation

Pearson, I. V., Hawe, E., Zuluaga, S., Wolowacz, S., & Haiderali, A. (2015). Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom. In [18], p. A455. .

Abstract